WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001035926) AN IMPROVED PHARMACEUTICAL COMPOSITION FOR TREATING MALE ERECTILE DYSFUNCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/035926    International Application No.:    PCT/IN2000/000105
Publication Date: 25.05.2001 International Filing Date: 24.10.2000
Chapter 2 Demand Filed:    04.06.2001    
IPC:
A61K 9/00 (2006.01), A61K 31/519 (2006.01)
Applicants: NATCO PHARMA LIMITED [IN/IN]; Natco House, Road No. 2, Banjara Hills, Hyderabad 500 033 (IN) (For All Designated States Except US).
VALLABHANENI, Ramakrishna, Rao [IN/IN]; (IN) (For US Only)
Inventors: VALLABHANENI, Ramakrishna, Rao; (IN)
Priority Data:
1128/MAS/99 18.11.1999 IN
Title (EN) AN IMPROVED PHARMACEUTICAL COMPOSITION FOR TREATING MALE ERECTILE DYSFUNCTION
(FR) COMPOSITION PHARMACEUTIQUE AMELIOREE POUR TRAITER LA DYSERECTION MASCULINE
Abstract: front page image
(EN)The invention disclosed in this application relates to a novel pharmaceutical composition containing sildenafil useful for nasal administration for the treatment of male erectile dysfunction due to organic, psychogenic and mixed causes. The composition is also effective in patients with erectile dysfunction due to spinal cord injury. The pharmaceutical composition of the present invention is in the form of a solution or a colloidal dispersion in a pharmaceutical vehicle filled into specially designed dosing device for nasal administration. The invention disclosed in this application also provides a method for preparing the pharmaceutical composition containing sildenafil for nasal application for the treatment of male erectile dysfunction.
(FR)La présente invention concerne une nouvelle composition pharmaceutique à base de sildénafil administrée par voie nasale pour traiter la dysérection masculine d'origines diverses, et notamment organique et psychogène. Cette composition est également efficace chez les patients souffrant de dysérection due à une lésion de la moelle épinière. par ailleurs, cette composition pharmaceutique se présente sous forme de solution ou de dispersion colloïdale contenue dans un excipient pharmaceutique et logée dans un doseur spécialement conçu pour l'administration par voie nasale. En outre, cette invention concerne un procédé de préparation d'une composition pharmaceutique à base de sildénafil devant être administrée par voie nasale en vue de traiter la dysérection masculine.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)